BAXALTA UK LIMITED
Company Information
- Company Number
- 09248888
- Registered Address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Status
- Dissolved
- Employee Count
- 0
- Turnover
- Coming Soon
- EBITDA
- £10,736,000
Additional Details
- Website
- https://takeda.com
- Company Type
- Private limited Company
- Incorporated On
- 3 October 2014
- Nature of Business
- 21100 - Manufacture of basic pharmaceutical products
- Industries
- Life Sciences And Medical Technology
- Region
- London
Time to Pay
Payment Timeline
Payment Features
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
Terms calculated from invoice date
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
60
Dispute Resolution Process
email apukssc@shire.com
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
BAXALTA UK LIMITED is a biopharmaceutical company that focuses on developing and delivering life-saving treatments for patients with rare diseases. They are committed to sustainability and have various initiatives in place to reduce their environmental impact.
The company's sustainability program includes efforts to reduce energy and water consumption, waste generation, and carbon emissions. They also prioritize responsible sourcing and ethical business practices.
BAXALTA UK LIMITED offers a range of products and services in the field of rare diseases, including treatments for hemophilia, immune deficiencies, and other genetic conditions. They also provide support and resources for patients and their families.
Key people in the company include the managing director, Mark Cipriano, and the head of sustainability, Thomas Koenig. The company's registered office address is located in Stockley Park, Uxbridge, and their website address is www.baxalta.co.uk.
In addition to their focus on sustainability, BAXALTA UK LIMITED is dedicated to improving the lives of patients with rare diseases through their innovative products and services. Their commitment to sustainability and patient care makes them a leader in the biopharmaceutical industry.
